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ABSTRACT
Objective: This study aimed to develop a selective analytical method for assessing disodium 5′-guanylate and disodium 5′-inosinate levels in flavor 
enhancers.
Methods: The levels were assessed using high-performance liquid chromatography (HPLC) with a photodiode array detector (PDA) (wavelength 
=255 nm) and a SunFire® C18 column (250 mm × 4.6 mm × 5 µm). The mobile phase comprised a mixture of potassium phosphate buffer and an 
ion pair reagent-hexane-1-sulfonic acid sodium salt - with a flow rate of 1.2 mL/min. The ion pair was used to generate a neutral equilibrium, which 
resulted in increased retention of the analytes. Optimized analysis conditions were then validated regarding accuracy, precision, linearity, selectivity, 
and the limits of detection and quantification.
Results: The average levels of disodium 5′-inosinate in the six analyzed samples were 0.24±1.46, 0.21±2.69, 0.58±3.26, 0.21±0.84, 0.22±3.59, and 
0.47±2.21%, respectively. Regarding disodium 5′-guanylate, the average levels were 0.15±2.85, 0.15±0.12, 0.41±3.80, 0.16±1.72, 0.27±1.18, and 
0.34±1.83, respectively.
Conclusion: The optimal conditions for analyzing disodium 5′-guanylate and disodium 5′-inosinateusing HPLC with a PDA and SunFire C18 column 
were λ=255 nm, a mobile phase of potassium phosphate buffer and sodium hexane sulfonate, and a flow rate of 1.2 mL/min. For disodium 5′-inosinate, 
its average levels in samples A–F were 0.24±1.46, 0.21±2.69, 0.58±3.26, 0.21±0.84, 0.22±3.59, and 0.47±2.21%, respectively. Meanwhile, the average 
levels of disodium 5′-guanylate in the samples were 0.15±2.85, 0.15±0.12, 0.41±3.80, 0.16±1.72, 0.27±1.18, and 0.34±1.83%, respectively.
Keywords: Disodium 5′-guanylate, Disodium 5′-inosinate, High-performance liquid chromatography; ion pair, Photodiode array.
INTRODUCTION
Flavor enhancers are used to maintain and improve the quality and 
stability of food. They are also used to maintain the nutritional value 
of food, which can be reduced during processing or packaging, to fulfill 
community needs [1].
Flavor enhancers are widely used in several countries, including 
Indonesia, because they can create a savory taste, also known 
as “umami.” Monosodium glutamate (MSG) is a white crystalline 
compound that is widely used as a flavor enhancer. In addition to 
MSG, the commonly used flavor enhancers in Indonesia include 
disodium 5′-inosinate and disodium 5′-guanylate. These compounds 
are categorized as nucleotide compounds that are generally used in 
conjunction with MSG to strengthen the flavor [2].
Disodium 5′-guanylate and disodium 5′-inosinate are metabolized 
in the body and absorbed in the duodenum. The nucleosides are 
actively absorbed, whereas purines are generally absorbed through 
passive diffusion mechanisms across the intestinal wall. Disodium 
5′-guanylate undergoes dephosphorylation to guanosine, followed 
by hydrolysis to guanine, deamination to xanthine, and oxidation to 
form uric acid. Meanwhile, disodium 5′-inosinate is derived from the 
dephosphorylation of ATP to AMP followed by deamination [3,4].
Although flavor enhancers are safe for consumption, their excessive use 
can endanger community health, and thus, further examination of these 
nucleotides needed. A quantitative analysis method that can determine 
the levels of flavor enhancers in small sample quantities is desired. 
Several methods have been previously used by researchers to analyze 
disodium 5′-guanylate and disodium 5′-inosinate levels.
Previous research conducted by Qiu et al., Vinas et al., and Yang 
et al. used high-performance liquid chromatography (HPLC) with a 
photodiode array detector (PDA) [2,5-9]. The mobile phase used by 
Qiu et al. and Vinas et al. was phosphate buffer and methanol. Yang 
et al. used a Pentadecafluorooctanoic acidion pair and methanol as 
the mobile phase. However, the researchers were unable to separate 
disodium 5′-guanylate and disodium 5′-inosinate through HPLC 
because the analyses were performed only by differentiating the pH 
and composition of the mobile phase.
Therefore, this study aimed to develop a more selective analytical 
method for assessing disodium 5′-guanylate and disodium 5′-inosinate 
levels using HPLC with a PDA.
METHODS
An LC-20AD HPLC system (Shimadzu) was equipped with a pump, 
SunFire® C18 column, PDA (SPDM-20A), manual injector, data processor, 
HPLC syringe (SGE), 0.45-μm-diameter Whatman membrane, oven, 
desiccator, analytical scales, volume pipette, latex balloons, and glass tools.
Six flavor enhancer samples (A–F) were generated using a standard 
mixture of disodium 5′-guanylate and disodium 5′-inosinate, bidistilled 
water, distilled water, potassium dihydrogen phosphate, sodium hexane 
sulfonate, phosphoric acid, and methanol.
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The standard mixture was generated by dissolving 100 mg each of 
disodium 5′-guanylate and disodium 5′-inosinate in 50 mL of distilled 
water in a 100-mL flask. The mixture was stirred until homogeneous. 
Then, 1-, 1.5-, 2-, 2.5-, 3-, and 3.5-mL aliquots of the 1000 mg/mL 
solution were added into a 10-mL flask, diluted with a solvent to 
obtain final concentrations of 100, 150, 200, 250, 300, and 350 mg/mL, 
respectively, and stirred until homogeneous.
The mobile phase was prepared by dissolving 17 g of potassium 
dihydrogen phosphate in 300 mL of bidistilled water in a 500-mL flask 
and stirring until homogenous (FI V, 2015). The pH was adjusted to 
3.50 ± 0.02 using phosphoric acid. To this mixture, 850 mg of sodium 
hexane sulfonate was added followed by dissolving and stirring until 
homogenous. The mixture was sonicated for 15 min.
The mobile phase composition, flow rate, and stability were assessed to 
optimize the analytical conditions. The mobile phase composition was 
examined by injecting 20 mL of a 200 mg/mL standard solution into the 
HPLC-PDA system at phosphate buffer/methanol ratios of 100:0, 95:5, 
and 90:10. The mobile phase composition was assessed on the basis 
of separation between the two compounds. The flow rate and column 
temperature were 1.2 mL/min and 30°C, respectively, and the analysis 
was performed twice for each composition.
The flow rate was optimized by first injecting 20 mL of the 200 mg/mL 
standard solution into the HPLC-PDA system using flow rates of 0.8, 
1, and 1.2 mL/min. The injection was performed twice for each flow 
rate. Stability testing was performed by injecting the same volume 
of the standard solution into the system on three consecutive days. 
Optimization was confirmed using the peak retention times, sharpness 
of the peak, and width of the analyte peak area.
The analytical methods were validated by creating a calibration 
curve through injecting 20-mL aliquots of the standard solution at 
concentrations of 100, 150, 200, 250, 300, and 350 mg/mL into the 
HPLC-PDA system under the selected analytical conditions. Regression 
of the peak area (y) against the analyte concentration (x) was analyzed, 
and the calibration curve was created. The correlation coefficient (r) 
of the linear regression equation was used to view the linearity of the 
curve by calculating the linearity factors of the line, that is, ri, ri2, VXO, 
and Δy/Δx.
The limits of detection (LOD) and quantitation (LOQ) were obtained 
by statistically calculating the calibration curve linear regression 









. In both 
formulas, b was the slope, and the calibration curve equation was 
y=bx+a. Furthermore, a selectivity test was conducted to compare the 
standard chromatogram with the sample chromatograms to identify 
impurity between the two compounds.
Four samples were created by added 600 mg of powder to a 20-mL 
volumetric flask together with one of three concentrations (100, 250, 
and 350 mg/mL) of the standard solution for the accuracy and precision 
tests. Six replicates were used for each concentration.
The measurement results in the recovery test can also be used to determine 
the thoroughness of the analytical method. Precision was measured as the 
standard deviation or relative standard deviation (r) ≤2%.
Samples A–F were prepared using the same treatment. In total, 
approximately 1.4 g of A, B, and D, 600 mg of samples C and F, and 2 mg 
of sample C were added into 20-mL volumetric flasks. Distilled water 
was added to the flasks to the specified limit, and the mixtures were 
stirred until homogenous. All samples were sonicated for 15 min and 
filtered into a 10-mL vial using 0.45-μm Whatman syringe filters.
The sample level was determined by injecting 20 mL of each sample 
into the HPLC system and measuring the width of the peak area. 
The experiment was repeated 3 times. The obtained uptake was 
incorporated into the calibration curve equation to determine the levels 
of the nucleotide in each sample.
RESULTS AND DISCUSSION
The results for mobile phase optimization are presented in Table 1.
Regarding the buffer mixture of potassium phosphate and sodium 
hexane sulfonate with methanol (100:0), the produced chromatograms 
could be separated well. Separation occurred between disodium 
5′-inosinate and disodium 5′-O-guanylate because the cluster on 
sodium hexane sulfonate in the mobile phase interacts with the amine 
group of disodium 5-guanylate. This interaction led to the formation 
of neutral ion pairs, making disodium 5′-guanylate less polar than 
disodium 5′-inosinate compound [10,11].
These findings resulted in short retention time for disodium 5′-inosinate, 
which eluted earlier than disodium 5′-guanylate. Concerning the 
95:5 and 90:10 mixtures of potassium phosphate and sodium hexane 
sulfonate with methanol, the generated chromatograms were less well 
separated than those for the 100:0 mixture.
At a flow rate of 0.8 mL/min, the retention times of disodium 
5′-inosinate were 4.616 and 4.580 min, whereas those of disodium 
5′-guanylate were 5.801 and 5.789 min. At 1.0 mL/min, the retention 
times of disodium 5′-inosinate were 3.276 and 3.251 min, compared 
to 4.160 and 4.155 min for disodium 5′-guanylate. At 1.2 mL/min, the 
retention times of disodium 5′-inosinate were 2.766 and 2.730 min, 
whereas those of disodium 5′-guanylate were 3.305 and 3.495 min. 
Thus, 1.2 mL/min was chosen as the optimal flow rate because it 
provided the fastest retention times.
In the stability test, the stabilities of both compounds decreased 
from the 1st day to 3rd day. The decline of stability was caused by the 
Table 1: Mobile phase optimization analysis of disodium 5′‑guanylate and disodium 5′‑inosinate
Mobile phase Compound Area (µV/s) Retention time (min) Following factor (Tf) HETP Theoretical plate value (N) Resolution
100:0 Inosinate 1,358,507 2.787 1.978 143.232 6981.698 3.786
Guanylate 2,967,251 3.865 1.338 95.821 10436.128
Inosinate 1,178,734 2.829 1.376 127.754 7827.517 2.648
Guanylate 2,916,445 3.872 1.344 92.119 10855.495
95:5 Inosinate 584,182 2.461 0.995 28.932 34563.568 1.123
Guanylate 2,468,073 2.627 1.652 82.398 12136.274
Inosinate 635,854 2.286 0.934 114.521 8732.022 0.965
Guanylate 2,253,558 2.505 1.724 166.123 6019.629
90:10 Inosinate 335,180 2.439 1.014 41.952 23836.689 1.192
Guanylate 2,548,024 2.635 1.598 91.697 10905.484
Inosinate 355,297 2.486 1.024 28.596 34970.289 0.907
Guanylate 2,592,340 2.674 1.606 89.485 11175.082
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instability of the two compounds during storage when dissolved in 
water. In this study, we determined that the disodium 5′-guanylate and 
disodium 5′-inosinate standard solution could be used for 2 days based 
on the wide peak areas on day 3.
The results obtained from the system suitability test met the system 
suitability test requirement because the r or repeatability values were 
≤2%. The system suitability test result illustrated that the current 
method might provide more optimal analysis conditions than those 
used in previous studies (Tables 2 and 3). The addition of sodium 
hexane sulfonate permitted the separation of disodium 5′-inosinate 
and disodium 5′-guanylate. In addition, short retention times were 
achieved using the current method, which should permit a relatively 
rapid analysis.
Linear regression calculation of the calibration curve obtained using 
six concentrations produced equations of y=6158.36x+216,232.90 
for disodium 5′-inosinate (Fig. 1) and y=12,950.90x+1,327,349.42 for 
disodium 5′-guanylate (Fig. 2). The linearity test results obtained from 
the calibration curve equations indicated that the compounds met the 
linearity test criteria because r for disodium 5′-guanylate was 0.99915 
and that for disodium 5′-inosinate was 0.99920.
The LOD for disodium 5′-inosinate was 5.34 mg/mL, and the LOQ was 
17.78 mg/mL. Meanwhile, the values for disodium 5′-guanylate were 
5.53 and 18.45 mg/mL, respectively. These results were much lower 
than those obtained in prior studies. Thus, we concluded that the 
current methods are superior to previously reported strategies.
The results of the selectivity test illustrated the absence of any 
interference or nuisance chromatogram at the retention times of 
disodium 5′-guanylate and disodium 5′-inosinate (Figs. 3 and 4). In 
the chromatogram, there was a small peak in the second minute that 
did not correspond to either compound (Fig. 4). However, no other 
aberrant peaks were observed. Thus, the developed method is selective 
for disodium 5′-inosinate and disodium5′-guanylate.
The accuracy and precision test results for disodium 5′-guanylate 
and disodium 5′-inosinate at three different concentrations met 
the criteria with values of 98–102%. In addition, the precision test 
data met the requirement of a relative standard deviation or of≤2% 
(Tables 4 and 5).
The assay results for the six samples of results assay of six samples of 
disodium 5′-guanylate and disodium 5′-inosinateare shown in Tables 6 
and 7.
Table 2: Results of the disodium 5′‑inosinate system suitability test
















Table 3: Results of the disodium 5′‑guanylate system suitability test
















Fig. 1: Calibration curve results for disodium 5′‑inosinate
Fig. 2: Calibration curve results for disodium 5′‑guanylate
Fig. 3: Selectivity test result for the standard solution of disodium 
5′‑guanylate and disodium 5′‑inosinate
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100.6 818,783 1,033,363 1,859,837 826 474 101.54 1.36 1.36 100.94
1,056,300 1,862,096 805 796 99.00 98.41
1,063,906 1,867,763 803 857 98.77 98.18
1,063,909 1,868,026 804 117 98.80 98.21
1,036,241 1,864,106 827 865 101.72 101.11
1,053,307 1,866,617 813 310 99.93 99.33
251.5 1,745,930 1,033,363 2,767,031 1733668 249.73 2.28 0.90 99.30
1,056,300 2,818,767 1762467 253.88 100.95
1,063,906 2,826,532 1762626 253.91 100.96
1,063,909 2,833,286 1769377 254.88 101.34
1,036,241 2,816,139 1779898 256.39 101.95
1,053,307 2,805,196 1751889 252.36 100.34
352.1 2,283,160 1,033,363 3,339,051 2305688 355.57 4.33 1.23 100.99
1,056,300 3,363,075 2306775 355.74 101.03
1,063,906 3,304,672 2240766 345.56 98.14
1,063,909 3,328,098 2264189 349.17 99.17
1,036,241 3,340,452 2304211 355.35 100.92
1,053,307 3,319,369 2266062 349.46 99.25


















101.4 2,190,785 2,574,667 4,771,224 2,196,557 101.67 0.76 0.75 100.26
2,599,811 4,798,040 2,198,229 101.74 100.34
2,649,174 4,830,181 2,181,007 100.95 99.55
2,659,993 4,886,124 2,226,131 103.04 101.61
2,607,785 4,789,689 2,181,904 100.99 99.59
2,618,648 4,819,113 2,200,465 101.85 100.44
253.3 4,721,283 2,574,667 7,386,952 4,812,285 258.39 1.95 0.76 101.93
2,599,811 7,367,856 4,768,045 256.01 100.99
2,649,174 7,397,280 4,748,106 254.94 100.57
2,659,993 7,370,878 4,710,885 252.94 99.78
2,607,785 7,407,074 4,799,289 257.69 101.65
2,618,648 7,385,116 4,766,468 255.92 100.96
354.9 6120917 2,574,667 8,780,940 6,206,273 359.85 1.50 0.42 101.39
2,599,811 8,772,823 6,173,012 357.92 100.85
2,649,174 8,785,150 6,135,976 355.77 100.25
2,659,993 8,836,908 6,176,915 358.15 100.91
2,607,785 8,805,541 6,197,756 359.36 101.26
2,618,648 8,817,616 6,198,968 359.43 101.28
Table 6: Assay results for disodium 5′‑inosinate
Sample Area (ΜV/s) Level (mg/mL) Average level (mg/mL) Content (%) Total per wrap (mg)
A 1,269,324 171.00 169.34 0.24±1.46 26.4
1,252,504 168.27
1,255,511 168.76
B 1,122,092 147.09 144.00 0.21±2.69 42.0
1,091,776 142.17
1,095,206 142.73
C 1,271,251 171.31 173.56 0.58±3.26 464.0
1,308,043 177.29
1,275,910 172.07
D 1,145,990 150.97 151.91 0.21±0.84 18.9
1,155,803 152.57
1,153,539 152.20
E 1,637,261 230.75 233.41 0.22±3.59 55.0
1,678,785 237.49
1,644,985 232.00
F 1,068,839 138.45 140.60 0.47±2.21 42.3
1,081,440 140.49
1,095,993 142.86
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Table 7: Assay results for disodium 5′‑guanylate
Sample Area (MV/s) Level (mg/mL) Average level (mg/mL) Content (%) Total per wrap (mg)
A 2,720,841 107.60 108.45 0.15±2.85 16.5
2,701,761 106.12
2,772,979 111.62
B 2,667,899 103.51 103.60 0.15±0.12 30.0
2,670,820 103.74
2,668,451 103.55
C 2,889,710 120.64 123.97 0.41±3.80 328.0
2,986,487 128.11
2,922,371 123.16
D 2,752,583 110.05 109.62 0.16±1.72 14.4
2,765,902 111.08
2,722,527 107.73
E 4,924,726 277.77 277.23 0.27±1.18 67.5
4,928,342 278.05
4,900,235 275.88
F 2,698,907 105.90 103.97 0.34±1.83 30.6
2,651,779 102.27
2,670,833 103.74
Fig. 4: Selectivity test result of the sample solution of disodium 
5′‑guanylate and disodium 5′‑inosinate
CONCLUSION
The optimal conditions for analyzing disodium 5′-guanylate and 
disodium 5′-inosinate using HPLC with a PDA and SunFire C18 column 
were λ=255 nm, a mobile phase of potassium phosphate buffer and 
sodium hexane sulfonate, and a flow rate of 1.2 mL/min.
For disodium 5′-inosinate, its average levels in samples A–F 
were 0.24±1.46, 0.21±2.69, 0.58±3.26, 0.21±0.84, 0.22±3.59, and 
0.47±2.21%, respectively. Meanwhile, the average levels of disodium 
5′-guanylate in the samples were 0.15±2.85, 0.15±0.12, 0.41±3.80, 
0.16±1.72, 0.27±1.18, and 0.34±1.83%, respectively.
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